On 10 May 2024, Xbrane and Stada announced the exclusive licensing agreement with US biosimilars specialist Valorum Biologics for their ranibizumab…...
Annual planning is a crucial process for organizations of all sizes. It allows businesses to set goals, allocate resources, and define strategies for…...